Ads
related to: scholarly articles on multiple sclerosis- Treatment FAQs
See Frequently Asked
Questions. Get The Answers.
- Patient Stories
See What Real Patients
Are Saying About This Treatment.
- Relapsing MS Treatment
Learn About A RMS
Treatment Option.
- Financial Resources
See Financial & Savings Info.
Learn About Savings Options.
- Clinical Results
View The Results Of
Clinical Studies Here.
- Patient Resources
Download Resources To
Learn More About Treatment.
- Treatment FAQs
Search results
Results From The WOW.Com Content Network
Research in multiple sclerosis may find new pathways to interact with the disease, improve function, curtail attacks, or limit the progression of the underlying disease. Many treatments already in clinical trials involve drugs that are used in other diseases or medications that have not been designed specifically for multiple sclerosis .
Multiple sclerosis can be pathologically defined as the presence of distributed glial scars (or sclerosis) in the central nervous system disseminated in time (DIT) and space (DIS). [2] The gold standard for MS diagnosis is pathological correlation, though given its limited availability, other diagnosis methods are normally used. [ 3 ]
Multiple sclerosis (MS) is an autoimmune disease resulting in damage to the insulating covers of nerve cells in the brain and spinal cord. [3] As a demyelinating disease , MS disrupts the nervous system's ability to transmit signals , resulting in a range of signs and symptoms , including physical, mental , and sometimes psychiatric problems.
Main symptoms of multiple sclerosis Symptoms and findings in multiple sclerosis. Multiple sclerosis can cause a variety of symptoms varying significantly in severity and progression among individuals: changes in sensation (hypoesthesia), muscle weakness, abnormal muscle spasms, or difficulty moving; difficulties with coordination and balance; problems in speech or swallowing (), visual ...
Multiple sclerosis (MS) can be pathologically defined as the presence of distributed glial scars in the central nervous system that must show dissemination in time (DIT) and in space (DIS) to be considered MS lesions. [1] [2] The scars that give the name to the condition are produced by the astrocyte cells attempting to heal old lesions. [3]
The Multiple Sclerosis Journal (formerly Multiple Sclerosis) is a monthly peer-reviewed medical journal covering the clinical neurology of multiple sclerosis. The editor-in-chief is Alan J Thompson (University College London). It was established in 1995 and is published by SAGE Publications. [1]
Ads
related to: scholarly articles on multiple sclerosis